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Abstract 
Intracellular persistence of bacteria represents a clinical challenge as bacteria can thrive in an 
environment protected from antibiotics and immune responses. Novel targeting strategies are critical in 
tackling antibiotic resistant infections. Synthetic antimicrobial peptides (SAMPs) are interesting 
candidates as they exhibit a very high antimicrobial activity. We first compared the activity of a library 
of ammonium and guanidinium polymers with different sequences (statistical, tetrablock and diblock) 
synthesized by RAFT polymerization against methicillin-resistant S. aureus (MRSA) and methicillin-
sensitive strains (MSSA). As the guanidinium SAMPs were the most potent, they were used to treat 
intracellular S. aureus in keratinocytes. The diblock structure was the most active, reducing the amount 
of intracellular MSSA and MRSA by two-fold. We present here a potential treatment for intracellular, 
multi-drug resistant bacteria, using a simple and scalable strategy.  
1. Introduction 
 
Staphylococcus aureus is one of the major causes of both community and hospital-acquired 
infections, methicillin-resistant S. aureus (MRSA) being associated with a mortality rate fivefold higher 
than that of methicillin-sensitive strains (MSSA) amongst patients in Europe.1-2 This issue is 
exacerbated with the ability of S. aureus to persist intracellularly.3-4 The presence of S. aureus inside 
epithelial and phagocytic cells has been associated with skin infections, tonsillitis and rhinosinusitis.5-8 
Unfortunately, the most commonly used antibiotics (such as vancomycin, oxacillin, and gentamycin) 
are not effective against intracellular bacteria as they are not efficiently internalized by the hosts cells, 
which allows S. aureus to survive.9-10 9-10 In order to overcome this barrier, antibiotic loaded liposomes 
and nanoparticles have been explored.11 These systems were internalized by infected mammalian cells 
2 | P a g e  
 
and efficiently killed intracellular bacteria.12-13 To circumvent the challenges associated with the 
stability and the drug loading efficiency of nanoparticles and liposomes, recent work has been focusing 
on the use of small molecule vectors capable of promoting intracellular delivery of antibiotics.14 
Amongst those systems, cell penetrating peptides (CPPs) conjugated to antibiotics significantly reduced 
bacterial growth in intracellular environments.15-16 However, the rapid development of resistance 
against antibiotics calls for more sustainable treatment.12, 17-19  
Antimicrobial peptides (AMPs) have been extensively investigated as their hydrophobic and 
cationic residues appear to efficiently disrupt bacterial membranes. Therefore, various studies have 
looked into their synthetic counterparts to improve their versatility and scalability.20-24 More importantly, 
synthetic antimicrobial peptides (SAMPs) seem to reduce the chance of bacteria developing resistance 
as they target bacterial membrane, as opposed to highly specific functions.25-26 Previous reports 
demonstrated that ammonium and guanidinium-rich SAMPs were potent against a wide spectrum of 
bacteria.27 Among those, arginine mimicking materials seemed particularly active against MRSA.  
In parallel, a range of guanidinium containing polymers were also synthesized to mimic 
CPPs.28-30 Although the mechanism of cell uptake has not been entirely elucidated, the guanidine 
moieties are thought to interact with membrane lipids via electrostatic interactions and H-bonds, 
followed by both endocytosis and direct diffusion through the membrane.31 The stereochemistry of the 
backbone was demonstrated not to impair the internalisation of the guanidinium polymers, but other 
parameters such as the number of guanidinium units or the overall hydrophobicity of the polymer were 
reported to alter cellular uptake.29, 32 By exploiting their antimicrobial activity of guanidinium rich 
polymers in combination with their ability to enter eukaryotic cells, this class of materials could be a 
promising alternative to antibiotics currently used against intracellular bacteria.33-34 In this case, the 
usual drawbacks associated with the use of a cargo such as drug attachment/ encapsulation or release 
would be bypassed, as the polymer is simultaneously holding a role of vector and drug. A guanidinium 
SAMP, polyhexamethylene biguanidine (PHMB), which is utilized as a disinfectant, has been reported 
to be efficient against intracellular S. aureus in keratinocytes.35-36 However, reports of its potential 
carcinogenic effects on humans, and increasing regulation over its use highlight the need for an 
alternative to PHMB.37 In the light of recent studies, improvement of the biological properties of this 
material can be obtained by modifying the distribution of cationic and hydrophobic functionalities along 
the backbone.38-39 Indeed, the segregation of the cationic and hydrophobic moieties appear to enhance 
the bactericidal effect, yet PHMB has an alternating sequence inherent to the nature of its synthesis. 
Varying the sequence of guanidinium containing polymers could potentially improve their intracellular 
activity. Therefore, the use of controlled polymerization techniques could provide viable alternatives to 
PHMB.  
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Previous reports described the synthesis of guanidinium containing polymers by post-polymerization 
functionalisation.34, 40 Guanidinium monomers could also be directly polymerized with or without Boc 
protecting groups using ROMP or RAFT.28, 32, 41-42 In addition to be suitable for various types of 
monomers, the latter technique has been utilized to prepare polymers with precisely defined 
compositions and narrow molar mass distributions.43-45  
Here, we synthesized ammonium and guanidinium containing SAMPs and studied their activity against 
MSSA and MRSA as well as their toxicity towards mammalian cells. Additionally, SAMPs with 
different monomer distributions (statistical, tetrablock and diblock) were synthesized via RAFT 
polymerization in order to establish a structure-activity relationship towards S. aureus. Our data 
demonstrate that these novel SAMPs are active against intracellular S. aureus within keratinocytes, 
indicating excellent potential in staphylococcal skin infection therapy.  
2. Materials and Methods 
 
2.1. Materials 
 
Acryloyl chloride, boron trifluoride diethyl etherate (BF3.OEt2), chloroform (CHCl3), dichloromethane 
(DCM), dicyano-1,4-benzoquinone (DDQ), 1,4-dioxane, ethylacetate (EtOAc), ethylenediamine, 1-
Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), N-hydroxysuccinimide (NHS), triethylamine 
(NEt3) and trifluoro acetic acid (TFA) were purchased from Sigma-Aldrich and used without further 
purification. 2,2'-azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride (VA-044, Wako), 4-
carboxybenzaldehyde (Alfa-Aesar), 2,4-dimethylethylpyrrole (Acros Organic) and propidium iodide 
(PI, Thermo-Fisher) were also used without further purification. Mili-Q water was directly used as a 
solvent for polymerizations. N-isopropylacrylamide (NIPAM, Sigma-Aldrich, 97 %) was used after 
purification by recrystallization in n-hexane. Nutrient Agar, Dulbecco's Modified Eagle's Medium 
(DMEM), Müller-Hinton Broth (MHB), Roswell Park Memorial Institute medium (RPMI-1640) , 
Phosphate Buffered Saline (PBS) tablets, Trypsic Soy Broth (TSB), Concanavalin A (Con A) and Triton 
X were purchased from Sigma-Aldrich. 96-well plates were sourced from Thermo-Fischer. Milli-Q 
filtered water was used to prepare solutions, according to their recommended concentration and the 
solutions were autoclaved prior to their usage in order to ensure sterility. Defibrinated sheep blood was 
obtained from Fisher Scientific. S. aureus strains USA 300 LAC JE2 and NCTC 8325 RN1 were from 
BEI Resources, USA. 
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2.2. Nuclear Magnetic Resonance (NMR) Spectroscopy.  
 
1H NMR spectra were recorded on a Bruker Advance 300 spectrometer (300 MHz) at 27 °C in DMSO, 
CDCl3 or D2O. For 1H NMR, the delay time (dl) was 2 s. Chemical shift values (δ) are reported in ppm. 
The residual proton signal of the solvent was used as internal standard.  
2.3. Size exclusion chromatography (SEC).  
Molar mass distributions were measured using an Agilent 390-LC MDS instrument equipped with 
differential refractive index (DRI), viscometry (VS), dual angle light scatter (LS) and dual wavelength 
UV detectors. The system was equipped with 2 x PLgel Mixed D columns (300 x 7.5 mm) and a PLgel 
5 µm guard column. The eluent was DMF with 5 mmol NH4BF4 additive. Samples were run at 1 mL 
min-1 at 50°C. Poly(methyl methacrylate) standards (Agilent EasyVials) were used for calibration. 
Analyte samples were filtered through a nylon membrane with 0.22 μm pore size before injection. 
Respectively, experimental molar mass (Mn,SEC) and dispersity (Đ) values of synthesized polymers were 
determined by conventional calibration using Agilent GPC/SEC software. 
2.4. Mass spectrometry (MS).  
MS analysis was carried out with Agilent1100 HPLC coupled with Agilent 6130B single quadruple 
mass spectrometer equipped with electrospray ionisation source. Mobile phases is 80% methanol with 
20% water at flow rate at 0.2 mL.min-1. Mass spectrometer was operated in electrospray positive ion 
mode with a scan range 50-500 m/z. Source conditions are: capillary at 4000V; nebulizer gas (N2) at 15 
psi; dry gas (N2) at 7 L.min-1; Temperature at 300 °C. Calibration was done with ESI tuning mix from 
Agilent. 
2.5. Fluorescence spectrometer.  
The fluorescent intensity was monitored using Agilent Technologies Cary Eclipse Fluorescence 
Spectrophotometer. The solutions of vesicles were introduced in a polystyrene cuvette for the 
measurements. 
2.6. High performance liquid chromatography (HPLC).  
HPLC was performed using an Agilent 1260 infinity series stack equipped with an Agilent 1260 binary 
pump and degasser.  The flow rate was set to 1.0 mL min-1 and samples were injected using Agilent 
1260 autosampler with a 100 μL injection volume.  The temperature of the column was set at 37 °C. 
The HPLC was fitted with an Agilent C18 column (100 x 4.6 mm) with 5 micron packing (100Ǻ). 
Detection was achieved using an Agilent 1260 variable wavelength detector. UV detection was 
monitored at λ = 309 nm. Methods were edited and run using Agilent OpenLAB online software and 
data was analysed using Agilent OpenLAB offline software. Mobile phase solvents used were HPLC 
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grade (ACN was ‘far UV’) and consisted of mobile phase A: 100 % ACN, 0.04 % TFA; mobile phase 
B: 100 % water, 0.04 % TFA with a gradient of 1 to 80 % ACN over 30 minutes. 
2.7. Dynamic Light Scattering (DLS) measurements.  
DLS measurements were taken using a Malvern instruments Zetasizer Nano at 37 °C with a 4 mW He-
Ne 633 nm laser at a scattering angle of 173° (back scattering). For DLS aggregation studies, 1.024 mg 
of polymer sample was dissolved in 1 mL of PBS buffer at pH 7.4 and a total of 0.5 mL of the solution 
was introduced in a 1.5 mL polystyrene cuvette after filtering with a 0.2 μm filter.  
2.8. Synthesis of N-t-butoxycarbonyl-N’-acryloyl-1,2-diaminoethane BocAEAM. 
The synthesis and polymerization conditions of BocAEAM has been described in a previous 
publication.39 
2.9. Synthesis of 2-[1,3-Bis(tert-butoxycarbonyl)guanidine]ethyl acrylamide (diBocGEAM0. 
The description of the synthesis of diBocGEAM can be found in the supplementary data. 
2.10. Typical synthesis of the statistical copolymer.  
Monomer(s), initiator, CTA and solvents were introduced in a test tube equipped with a mechanical 
stirrer and a rubber septum (Table SI-2 for the quantity of reagents needed for the statistical copolymers). 
The solution was degassed with nitrogen for ca. 15 min and the polymerization was then performed in 
a thermostated oil bath. After the desired polymerization time, the test tube was withdrawn from the oil 
bath. 
2.11. Typical synthesis of block copolymers. 
Typical synthesis of the initial block. Monomer, initiator, CTA and solvents were introduced in a test 
tube equipped with a mechanical stirrer and a rubber septum (Tables SI-3, SI-4 and SI-5 for the quantity 
of reagents needed for the diblock and multiblock copolymers). The solution was degassed with 
nitrogen for ca. 20 min and the polymerization was then performed in a thermostated oil bath at 46 °C. 
After 20 hours, the test tube was withdrawn from the oil bath and a sample was taken for 1H NMR and 
SEC analysis. 
Typical synthesis of subsequent blocks. The test tube with the reaction mixture was opened and 
additional monomer, initiator and solvent were introduced. After the mixture was sealed with a septum, 
the solution was degassed for ca. 20 min, then placed in an oil bath set at 70 °C for the polymerization 
to occur. The tube was withdrawn from the oil bath after 2 hours and a sample was taken for 1H NMR 
and SEC analysis. 
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2.12. Deprotection of the polymers 
The polymers were dissolved in TFA and stirred for 3 hours at 40 °C. The TFA was then removed and 
the polymers were precipitated in diethyl ether. In order to remove the TFA counter-ion, the polymers 
were dialysed against a NaCl solution, followed by dialysis against distilled water. 
2.13. Synthesis of Bodipyacrylamide (BodipyAM) 
The description of the synthesis of BodipyAM can be found in the supplementary data. 
2.14. Chain extension of the deprotected polymers with BodipyAM  
polyGEAm-co-NIPAm (13.9 mg, 1 μmol) was dissolved in an acetate buffer (pH 5). A solution of 
Bodipy acrylamide (0.5 mg, 1 μmol) in acetone was added, as well as a solution of VA-044. The reaction 
mixture was degassed for 15 min, then placed in an oil bath at 46 °C for 5 hours. The polymer was then 
precipitated in Et2O. 
2.15. Hemolysis and hemagglutination assays 
Sheep red blood cells (RBCs) were prepared by washing defibrinated sheep blood with PBS via 
centrifugation. Polymers were dissolved in PBS. The normalisation was done using positive controls 
(50 μg mL-1 Concanavalin A for hemagglutination and 2 % Triton X-100 in PBS for hemolysis) and 
negative control (PBS) which were included on each plate. A suspension of 3 % in volume of RBCs 
was added to each well and the contents were mixed before being incubated at 37°C for 2 hours. The 
96-well plates were centrifuged at 600 x g for 10 minutes then 100 μL of the supernatant was transferred 
into a new plate. The absorbance at 540 nm was measured and normalized using the positive and 
negative control. 
2.16. Eukaryotic Cell Lines and Growth Conditions 
HaCaT human keratinocytes were grown in a 50:50 mixture of Ham’s F12 and Dulbecco's Modified 
Eagle's Medium (DMEM) supplemented with 10% of foetal calf serum, 1% of 2 mM glutamine and 
1%. Both cell lines were grown as adherent monolayers at 37 °C in a 5% CO2 humidified atmosphere 
and passaged at approximately 70-80% confluence. 
2.17. In vitro growth inhibition assays 
The anti-proliferative activity of the polymers was determined in HaCaT human keratinocytes. 96-well 
plates were used to seed 5000 cells per well which were left to pre-incubate with drug-free medium at 
37 °C for 24 hours before adding different concentrations of the compounds to be tested (1024 µg mL-
1 – 32 µg mL-1). A drug exposure period of 24 hours was allowed. The XTT assay was used to determine 
cell viability. The IC50 values (concentrations which caused 50% of cell death), were determined as 
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duplicates of triplicates in two independent sets of experiments and their standard deviations were 
calculated. 
2.18. Bacterial Strains and Growth Conditions 
The utilized bacterial strains were S. aureus USA 300 LAC JE2 and NCTC 8325 (RN1). Bacteria were 
grown in TSB at 37°C at 250 rpm for 18 hours. 
2.19. Antibacterial susceptibility tests 
Antibacterial susceptibility was studied using two strains of Staphylococcus aureus (S. aureus): RN1 
and JE2. Minimum inhibitory concentrations (MICs) were determined according to the standard 
Clinical Laboratory Standards Institute (CLSI) broth microdilution method (M07-A9-2012). A single 
colony of bacteria was picked up from a fresh (24 hour) culture plate and inoculated in 5 mL of Mueller-
Hinton (MH) broth, then incubated at 37 °C overnight. On the next day, the concentration of cells was 
assessed by measuring the optical density at 600 nm (OD600). Culture suspension was then diluted to an 
OD600 = 0.1 with MHB in order to reach a bacterial concentration of ~ 108 colony forming unit per mL 
(CFU mL-1). The solution was diluted further by 100 fold to obtain a concentration of 106 CFU mL-1. 
Polymers were dissolved in MHB and 100 μL of each test polymer was added to micro-wells followed 
by the addition of the same volume of bacterial suspension (106 CFU mL-1). The micro-wellplates were 
incubated at 37 °C for 24 hours, and growth was evaluated by measuring the OD600 using a plate reader. 
Triplicates were performed for each concentration and readings were taken twice. The growth in the 
well was normalized using negative controls, wells without any bacteria introduced, and positive 
controls, wells only containing bacterial solution. 
2.20. Binding assay 
Interactions of fluorescent polymers with bacterial membrane was investigated using the MRSA strain 
of S. aureus. A colony was inoculated in 5 mL of TSB at 37 °C overnight. The inoculum was diluted to 
reach an OD=0.15, then it was incubated for 2 hours to reach OD=1. 1 mL of the suspension was 
centrifuged at 5000 rpm for 5 minutes. The bacteria were resuspended in a solution containing 
fluorescent polymer at a concentration of 128 μg.mL-1 in PBS. The bacteria were incubated at 37 °C for 
15 minutes, 30 minutes or 2 hours whilst shaking at 500 rpm. For the experiments with PI, 15 minutes 
prior to the end of the incubation time, a solution of PI was added to reach a final concentration of 30 
μM. At the end of the incubation time, the bacteria were centrifuged, the pellet washed with PBS, then 
resuspended in 100 μL of PBS, of which 5 μL was placed on an agarose gel covering a glass slide. Upon 
drying, 20 μL of DAPI was added and the cover slip was placed on the sample. The slides were then 
imaged using a Leica DMi8 fluorescence microscope equipped with a FITC filter (480nm/40) used to 
view BodipyAM and a TXR filter (560nm/40) to image PI. 
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2.21. Cell uptake assay 
HaCaT cells were seeded (2 104 cells/well) in a black 96-well plate with clear bottom. After 24 hours, 
the cells were incubated with fluorescent polymers (128 and 40 μg.mL-1) for 2 or 16 hours depending 
on the specified conditions. In order to stain the nucleus of the cells, Hoescht 33342 was added to each 
well 15 minutes prior to the end of the incubation time. For the experiment performed at 4 °C, the plate 
was placed in the fridge 30 min prior to the polymer treatment. The wells were viewed after washing 
and replacing with fresh media using a Cytation3 Cell Imaging Multi-Mode ReaderTM from Biotek®.  
Gen5TM was used to isolate individual cells with the blue channel. The background was removed with 
a rolling ball model (20 µm) and intracellular fluorescence was determined using the RFP filter (λex = 
531 nm, λem = 593 nm) to view the Bodipy-functionalized polymers. Two separate experiments were 
conducted with triplicates. 
2.22. Invasion assay 
The intracellular infection was performed on HaCaT cells using RN1 and JE2. 24-well plates were used 
to seed 2 105 cells per well which were left to pre-incubate with antibiotic-free medium at 37 °C for 10 
hours. A single colony of bacteria was inoculated in TSB at 37 °C overnight. The inoculum was diluted 
to reach an OD=0.15 and were incubated for 2 hours to reach OD=1. After a 1:200 dilution, 1 mL of 
the bacterial solution was added in each well and the cells were incubated for another 2 hours at 37 °C. 
The medium was then removed and the wells were washed with 1 mL of PBS. 500 μL of a solution of 
50 μg.mL-1 of gentamicin and 20 μg.mL-1 of lysostaphin in DMEM was added and the plate was left at 
37 °C for 30 min to kill the extracellular bacteria. The solution was removed and the wells were washed 
with PBS. 500 μL of polymer solution was added and the plate was incubated at 37 °C for 2 hours, 
using a solution of 5 μg.mL-1 of lysostaphin as a negative control. 1 mL of a solution of 0.5 % of saponin 
was added to disrupt the membrane of mammalian cells. After 10 minutes at 37 °C, serial dilution of 
each well in PBS was undertaken following a thorough detachment of the cells. Each serial dilution was 
then plated on an Agar plate and left in the incubator overnight. The number of bacteria was counted 
on the next day. 
2.23. Statistical analysis of data 
The statistical significance of the differences between cfu/mL recovered from various groups was 
analysed using the One-way ANOVA test. Differences were considered significant if P ≤ 0.05. 
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3. Results and discussion 
 
3.1. Synthesis and characterisation of ammonium and guanidinium polymers via RAFT 
In order to study the effect of the type of cationic group on the polymer activity against MSSA 
and MRSA, we used acrylamide monomers, guanidino-ethylacrylamide (GEAM) and amino-
ethylacrylamide (AEAM), mimicking arginine and lysine respectively. The acrylamide monomer 
family is particularly suitable for the synthesis of multiblock copolymers via RAFT since they possess 
a high rate constant of propagation (kp) and therefore, it is possible to polymerize them to high 
conversion with much lower initiator concentrations than other monomer families, such as 
methacrylates.46 GEAM and AEAM monomers were synthesized with Boc protecting groups 
(diBocGEAM and BocAEAM, respectively) in order to avoid any aminolysis of the trithiocarbonate of 
the RAFT agent during the polymerization process (Figures SI-1, SI-2, SI-3). BocAEAM and 
diBocGEAM were both obtained with high yields in two-step syntheses as described in the literature.32, 
39 They were then separately copolymerized with N-isopropylacrylamide (NIPAM), which in 
combination with AEAM at 70:30 molar ratio, has been shown to reduce the toxicity towards 
mammalian cells of cationic copolymers while maintaining antimicrobial properties.39 Therefore, all 
polymers in this study were synthesized with 30 molar % of cationic monomer. The RAFT agent used 
for the synthesis was (propanoic acid)yl butyl trithiocarbonate (PABTC) as it is suitable for the 
polymerization of acrylamides and its synthesis is facile and scalable.39 
For each set of monomers (BocAEAM and diBocGEAM with NIPAM), a statistical, tetrablock 
and diblock copolymers (Figure 1A) was synthesized to study the influence of monomer distribution 
on the antimicrobial activity. The final targeted degree of polymerization (DP) was 100 for all the 
polymers, thus the shortest cationic blocks were of DP 15 (for the tetrablocks), which is expected to be 
high enough to ensure that the majority of polymer chains possess the correct monomer sequence.47 All 
materials will be referred below according to the type of charge (G for guanidinium and A for 
ammonium), the amount of charge (here 30 molar % for all the polymers), their sequence (S for 
statistical, T for tetrablock and D for diblock) and labelled Boc when in their protected form (Table 1).  
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Table 1. Synthesized Boc-protected polymers. 
Co-monomer Segmentation Composition Label 
Amino-
polymers 
Statistical NIPAM70-s- BocAEAM30 A-S30Boc 
Diblock NIPAM70-b- BocAEAM30 A-D30Boc 
Tetrablock 
NIPAM35-b- BocAEAM15-b-
NIPAM35-b- BocAEAM15 
A-T30Boc 
Guanidino-
polymers 
Statistical NIPAM70-s- diBocGEAM30 G-S30Boc 
Diblock NIPAM70-b- diBocGEAM30 G-D30Boc 
Tetrablock 
NIPAM35-b- diBocGEAM15-
b-NIPAM35-b- diBocGEAM15 
G-T30Boc 
 
The polymerization of BocAEAM and diBocGEAM required higher initiator concentrations 
than for the polymerization of NIPAM. Furthermore, the first polymerization cycle generally requires 
a higher initiator concentration than subsequent polymerization cycles in order to fully consume the 
initial CTA.48 Since the polymerization of NIPAM required lower concentrations of initiator to achieve 
full monomer conversion, it was selected as the first block in each block copolymer synthesis in order 
to preserve a higher fraction of living chains going into subsequent block extensions. The 
polymerization of diBocGEAM was undertaken at 46 °C since a loss of molar mass control was 
observed at higher temperatures. The reaction conditions were optimized to maintain a high livingness 
of the polymer chains, which is necessary for the synthesis of multiblock copolymers (Tables SI-1 to 
SI-4).48-49 Under these conditions, full monomer conversion was reached for each chain extension, 
allowing for the synthesis of the block copolymers in one pot (Figures 1B and SI-4). All polymers were 
obtained with the targeted molar mass and a low dispersity (Đ ≤ 1.24) according to SEC analysis 
(Figures 1C, SI-5 and SI-6, Table SI-5). A shift to higher molar mass after each chain extension was 
confirmed with the SEC traces, but in most cases the experimental molar mass Mn,SEC did not match the 
theoretical one Mn,th (Table SI-5), which can be explained by the nature of the PMMA standards used 
for the calibration of the instrument. 
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Figure 1. Synthesis of the polymer library. (A) Schematic of the ammonium and guanidinium 
polymer library. (B) 1H NMR spectra in DMSO-d6 of the successive chain extensions for the synthesis 
of G-T30Boc. (C) DMF-SEC chromatograms of the successive chain extensions for the synthesis of G-
T30Boc. (D) RP-HPLC chromatograms of the ammonium and the guanidinium polymers with a gradient 
of 1 to 80 % ACN in 30 minutes with a 100 mm C18 column. 
 
Following the polymerization process, the protected guanidinium copolymers were deprotected 
using TFA, with quantitative deprotection confirmed using 1H NMR in D2O (Figure SI-7). This 
deprotection method further justifies the choice of acrylamide monomers as they are more stable 
towards hydrolysis than acrylates or methacrylates.50 The cationic polymers were then dialysed against 
a solution containing NaCl to replace the TFA counter-ions with Cl- as shown by 19F NMR (Figure SI-
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8), and finally against distilled water to remove any traces of excess NaCl. The polymers were obtained 
as solids after freeze-drying.  
To identify the effect of monomer distribution on the physico-chemical properties of the 
polymer library, which could in turn alter their biological activity, characterisation of the polymers by 
reverse phase HPLC (RP-HPLC) was performed (Figure 1D, Table SI-6). The elution time of the 
polymers can be correlated to their hydrophobicity, where earlier elution times indicate less 
hydrophobicity. Preceding work examining the ammonium counterparts, but also other types of 
polyacrylamide-based multiblock copolymers established a comparable trend between elution time of 
the polymers with different composition and hydrophobicity.51 RP-HPLC of the guanidinium polymers 
indicated the following trend, with hydrophobicity of the polymers decreasing left to right; diblock (G-
D30) > tetrablock (G-T30) > statistical (G-S30). Moreover, Hou et al. utilized copolymers of NIPAM 
and N-vinylcaprolactam to demonstrate that the cloud point temperature of the statistical copolymer 
was higher than that of the diblock.52 This observation was attributed to the increase of the overall 
hydrophobicity of the polymer chain with the segregation of the monomer types along the backbone. 
Similarly, in the case of G-D30, G-T30 and G-S30, the size of the discreet hydrophobic segments (here 
the polyNIPAM block) are likely affecting the overall hydrophobicity of the polymer structures. The 
amphiphilic balance of cationic polymers strongly affects their membrane interactions and will not only 
alter their antimicrobial properties, but also their internalisation in mammalian cells.32 
Next, the behaviour of the copolymers in solution was analysed by DLS at 37 °C and pH 7.4 at the 
maximum concentration tested for the biological experiments (1024 μg.mL-1). Since polyNIPAM is 
known to possess a lower critical solution temperature (LCST) in aqueous solution close to 
physiological temperatures, it was pertinent to demonstrate that the copolymer do not self-assemble.53 
No self-assembly was observed for both the ammonium and guanidinium copolymers (Figure SI-9, 
Table SI-6). These results are in agreement with the general observation that the LCST of polymers 
increases when they are copolymerized with a non-temperature-responsive monomer.54 Since no 
micellar formation was observed, any difference in the activity of the polymers can be directly 
correlated to the monomer sequence. 
 
3.2. Synthesis of Bodipy acrylamide and fluorescent guanidinium polymers 
 
In order to carry out binding or cell uptake assays, the guanidinium polymers were functionalized 
using a Bodipy dye. Bodipy-derived dyes are known to have a high quantum yield and have been 
extensively used to label polymers.55 Here, we synthesized an acrylamide derivative of the Bodipy dye 
to incorporate into the guanidinium copolymers via RAFT polymerization. Firstly, Bodipy acid was 
synthesized after 2 steps according to the literature (Figure SI-10).56 The obtained compound was then 
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modified to obtain a NHS-functionalized Bodipy (Figure SI-11). This NHS-Bodipy was then converted 
into an acrylamide by using the AEAM monomer, recovered from the deprotection of BocAEAM 
(Figure SI-12). As the AEAM monomer is not soluble in organic solvents, the Bodipy acid was 
functionalized with NHS in DMF before reaction with AEAM in water, to limit hydrolysis. The 
obtained BodipyAM was fluorescent with λex=525 nm and λem=537 nm (Figure SI-13). The 
guanidinium polymers were then chain extended with one unit of BodipyAM per polymer chain using 
a RAFT process. The polymerizations were performed in a mixture of an acetate buffer at pH 5 to limit 
aminolysis and acetone to solubilize BodipyAM. The excess dye was removed by further diluting the 
mixture with acetone followed by a precipitation in diethyl ether. The Bodipy labelled statistical, 
tetrablock and diblock copolymers (G-S30Bodipy, G-T30Bodipy and G-D30Bodipy, respectively), which 
contained less than 5 % of free dye, were characterized using fluorescence spectroscopy and HPLC 
(Figure SI-14). 
 
3.3. Toxicity of SAMPs towards mammalian cells 
Hemocompatibility of SAMPs. As cationic polymers are known to be hemotoxic, defibrinated sheep 
blood was used to assess the hemocompatibility of the synthesized polymers up to 1024 μg.mL-1 over 2 
hours at 37 °C, according to an adapted protocol from the literature.34, 57 Remarkably, none of the 
ammonium polymers were hemolytic in contrast to Triton X, which was used as a positive control 
(Figure SI-15A). Amongst the guanidinium polymers, G-D30 induced 10% hemolysis at a 
concentration of 1000 μg.mL-1, while the statistical and tetrablock counterparts (G-S30 and G-T30) 
were not hemolytic within the concentration range tested (Table 2, Figure SI-15B).  
Since the hemocompatibility of polymers encompasses both hemolytic and hemagglutination, the latter 
was studied with defibrinated sheep blood, and Concanavalin A as a positive control.58 A-S30 and A-
T30 induced hemagglutination, from concentrations of 64 and 128 μg.mL-1, respectively (Table 2), 
whereas A-D30 did not. These results are consistent with those obtained from a previous study, where 
the heptablock and statistical poly(NIPAM-co-AEAM) also induced the formation of RBC aggregates 
whilst the diblock copolymer did not exhibit any toxicity.39 These observations could be explained by 
the distribution of cationic functionalities along the polymer backbone facilitating the cross-linking of 
RBCs. Similarly, for guanidinium polymers, the aggregation of RBCs was observed with G-S30 and 
G-T30, from concentrations of 8 and 32 μg.mL-1, respectively, while G-D30 as well as A-D30 did not 
induce hemagglutination (Tables SI-7 and SI-8). The polymers which induced aggregation of red blood 
cells (statistical and tetrablock copolymers) were not hemolytic, suggesting that each aspect of 
hemotoxicity are relatively independent for the investigated materials. Combined, hemolysis and 
hemagglutination assays revealed that the diblocks A-D30 and G-D30 were the most hemocompatible 
systems, whereas the statistical and tetrablocks induced hemotoxicity at low concentrations (Table 2). 
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Compatibility of SAMPs with human cells. As S. aureus was shown to persist within keratinocytes 
during skin infections, SAMPs need to exhibit a low toxicity towards these cells to warrant their clinical 
application.2, 59 The toxicity of the two sets of polymers against human keratinocytes (HaCaT) was 
evaluated over a period of 24 hours using an XTT assay. The toxicity of the amine polymers towards 
HaCaT was surprisingly low, with an IC50>1000 μg.mL-1 for all three compositions (Figure 2A), 
indicating that the monomer sequence did not influence the toxicity of these polymers at the tested 
concentrations. For each copolymer composition, the guanidinium polymers were shown to be more 
toxic than their corresponding ammonium polymers. The difference between the two tetrablock 
copolymers (A-T30 and G-T30) and the two diblock copolymers (A-D30 and G-D30) was particularly 
significant (Figure 2A). This result is in agreement with a previous reported work studying 
methacrylamide-based statistical copolymers containing guanidinium and ammonium moieties.60 By 
increasing the ratio of guanidinium to ammonium functionalities, the toxicity of the polymers were 
shown to increase towards MCF-7 epithelial cells. Indeed, due to their similarity to arginine-rich CPPs, 
the guanidinium polymers could undergo enhanced interactions with mammalian cell membranes 
compared to their ammonium counterparts, which would affect their toxicity.61 Furthermore, 
segregation of cationic and hydrophobic functionalities also significantly increased the toxicity of the 
ammonium and guanidinium SAMPs towards epithelial cells.  According to the IC50 values (Table 2), 
G-D30 appeared to be the most toxic, followed by G-T30 and G-S30. The toxicity observed with each 
polymer composition correlates to their overall hydrophobicity (determined via RP-HPLC, Figure 1), 
indicating that an increase in hydrophobicity accounts for an increase in toxicity. Similarly, Neanmark 
and co-workers reported an increase in cytotoxicity with hydrophobicity by using poly(ethylenimine)s 
bearing aliphatic substituents of varying lengths.62  
 
 
Figure 2. Cytotoxicity of ammonium and guanidinium copolymers against (A) HaCaT cells and 
(B) A549 cells.  Cell viability after a 24-hour incubation in presence of statistical, tetrablock and diblock 
ammonium and guanidinium SAMPs using an XTT assay. 
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As pneumonia is another common ICU-acquired infection associated with S. aureus, the 
toxicity of the polymers towards lung epithelial cells (A549) was also evaluated over the course of 24 
hours using an XTT assay (Figure 2B).63 With A549 cells, A-T30 and A-D30 were found to be toxic at 
relatively high concentrations (IC50 of 700 and 400 μg.mL-1), while the guanidinium counterparts were 
again more toxic. Similarly, the IC50 decreased with increasing segregation of the co-monomers (G-S30 
> G-T30 > G-D30 as shown in Table 2). Taken together, the toxicity data revealed that toxicity increases 
with segregation, which has not been demonstrated before, to the best of our knowledge. 
Table 2. Toxicity values of the SAMPs against RBCs, HaCaT and A549 cells. 
 
Hemocompatibility IC
50
[c] (μg.mL
-1
) 
HC
10 
[a] (μg.mL
-1
) c
H
[b]
 
(μg.mL
-1
)
 
HaCaT A549 
A-S30 > 1024 64 > 1024 > 1024 
A-T30 > 1024 128 > 1024 700 
A-D30 > 1024 > 1024 > 1024 400 
G-S30 > 1024 8 > 1024 600 
G-T30 > 1024 32 500 200 
G-D30 1024 >1024 300 150 
[a] HC10 is the minimum concentration at which at least 10 % of the maximum lysis was observed. 
[b] cH is the lowest concentration at which the polymers induce aggregation of RBCs. 
[c] IC50 was determined as the concentration at which 50 % of cell growth inhibition occurred. 
 
3.4. Antimicrobial activity of SAMPs 
Two clinically relevant strains of S. aureus were used to evaluate their antimicrobial susceptibility 
towards the synthesized polymers: RN1 (NCTC 8325), a MSSA strain, which is widely used laboratory 
strain, and USA300 JE2, a MRSA strain, which is considered to be more virulent than RN1.64-65 
For both the ammonium and guanidinium polymers, the monomer distribution had a significant 
effect on their efficacy against S. aureus (Table 3). MIC against RN1 decreases with the segmentation 
for both sets of polymers (Figures 3A and B). The ammonium and guanidinium polymers with the same 
sequence had similar MICs against the MSSA strain. The statistical copolymers (A-S30 and G-S30) 
appeared to be inactive against RN1 within the concentration range tested (MIC>1000 μg.mL-1), 
whereas the tetrablock and diblock copolymers exhibited relatively low MIC values (from 128 and 64 
μg.mL-1, respectively). G-D30 an A-D30 were the most active against RN1 with a MIC of 64 μg.mL-1. 
A similar trend was observed with the MRSA strain for both sets of polymers, as the antimicrobial 
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activity increased with the segregation of functionalities (Figure 3B). Strikingly, the MIC values of G-
T30 and G-D30 against JE2 (128 and 64 μg.mL-1, respectively) were decreased by two-fold compared 
to A-T30 and A-D30 (256 and 128 μg.mL-1, respectively) (Figure 3B). Since the molar mass of the 
ammonium and guanidinium polymers are comparable (Table SI-6), the difference in the MIC values 
strongly suggests that the guanidinium copolymers were more potent than the ammonium counterparts, 
which is consistent with a previous study.34 While the role of polymers bearing amine moieties appear 
to derive from their attachment to bacterial membranes followed by the formation of pores, polymers 
bearing guanidinium moieties could have a different antimicrobial mechanism. Indeed, the binding of 
guanidine units to phospholipids from bacterial membrane was shown to be more labile, hence allowing 
an efficient membrane crossing.66 Recently, Good and co-workers reported that the antimicrobial 
activity of polyhexamethylene biguanidine is attributed to its differential access to, and subsequent 
condensation of, bacterial DNA over mammalian DNA, thereby inducing bacterial death.67  
 
Figure 3. Antimicrobial activity of SAMPs against S. aureus. (A) MIC values of the ammonium and 
guanidinium polymers against RN1. (B) MIC values against JE2 as described in (A). 
 
The MIC of A-T30 and A-D30 against JE2 (256 and 128 μg.mL-1, respectively) was double 
that observed against RN1 (128 and 64 μg.mL-1, respectively) as shown on Table 3. It is plausible that 
JE2 and RN1, by virtue of their dissimilar methicillin-susceptibility, have different membrane 
compositions and physical properties (thickness, surface charge), which has been shown to influence 
the sensitivity of bacteria towards SAMPs.68-69 Thus, the more hydrophobic the polymer, the more toxic 
it is towards mammalian cells but also towards bacteria.  
 
 
 
17 | P a g e  
 
Table 3. Biological properties of ammonium and guanidinium SAMPs. 
 
MIC[a] (μg.mL
-1
) 
MIC[a] 
(nmol.mL
-1
) 
Selectivity with RBCs[b] 
Therapeutic Index (TI) 
[c] with HaCaT 
RN1 JE2 RN1 JE2 RN1 JE2 RN1 JE2 
A-S30 > 1024 > 1024 > 75 > 75 < 0.1 < 0.1 < 1 < 1 
A-T30 128 256 10 20 1 0.5 > 8 > 4 
A-D30 64 128 5 10 > 16 > 8 > 16 > 8 
G-S30 > 1024 > 1024 > 75 > 75 < 0.1 < 0.1 < 1 < 1 
G-T30 128 128 10 10 0.3 0.3 4 4 
G-D30 64 64 5 5 16 16 5 5 
[a] MIC is the minimum inhibitory concentration at which no visible bacteria growth can be observed. 
[b] Selectivity: lowest value between HC10 and cH (hemocompatibility concentration) divided by the MIC of the 
bacterial strains concerned. 
[c] Therapeutic index (TI) was calculated as the HaCaT IC50 of the SAMP to the MIC of the bacteria species. 
 
3.5. Interactions of the guanidinium polymers with bacterial membrane 
The variation in the MIC values between G-S30, G-T30 and G-D30 could either be explained 
by a difference in binding or ability to disrupt bacterial membrane. In order to determine if the binding 
efficiency between bacteria and guanidinium copolymers was influenced by monomer distribution, the 
Bodipy-functionalized guanidinium polymers were utilized. In mass concentration, the MIC of the 
fluorescent polymers were double that of their unlabelled counterparts (256 and 128 μg.mL-1 for G-
T30Bodipy and G-D30Bodipy, respectively) as shown in Table SI-9. Although the MIC values of the 
fluorescent polymers (in molar concentration) against both RN1 and JE2 were slightly higher to that of 
the unlabelled polymers, the polymers maintained a significant antimicrobial activity after incorporation 
of BodipyAM, in turn validating the observations of the experiment (Table SI-9). The MRSA strain JE2 
was incubated at 37 °C with each polymer at a concentration of 128 μg.mL-1 for 15, 30 and 120 minutes 
(Figure 4). For the 30 and 120 minute time points, propidium iodide (PI), which stains bacteria 
possessing a compromised membrane, was added 15 minutes prior to the end of the experiments. As 
there was no staining with PI for the 15 minute time point, in order to demonstrate that the bacterial 
binding of guanidinium polymers is independent of the presence of PI, Figure 4A displays only the 
brightfield (BF) and green channel (including a merge of the two). Microscopy revealed that G-D30Bodipy 
clearly attached to bacteria within 15 minutes of incubation as illustrated in Figure 4A.  According to 
the BF image, the bacteria appeared to be compromised in the presence of G-D30Bodipy, as the shape of 
the majority of the bacterial population is poorly defined. In contrast, G-S30Bodipy and G-T30Bodipy did 
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not appear to bind bacteria as effectively within this timeframe, evidenced by the absence of noticeable 
fluorescence in the green channel. Additionally, the shape of the bacteria remained intact, indicating 
that the polymers did not compromise bacterial membrane. 
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Figure 4. Bacterial membrane interactions of SAMPs. Binding assay with JE2 of the guanidinium 
SAMPs after 15 minutes without PI (A) Binding assay with JE2 after 30 minutes in presence of PI (B) 
Binding assay with JE2 after 2 hours in presence of PI, no image was presented for G-D30 after 2 hours 
no bacteria were left under these conditions (C). The scale bar represents 5 µm. 
 
For the 30 minute time-point, Figure 4B displays images from the BF, Bodipy, PI channels and 
a merge of the Bodipy and PI channels. Following 30 minutes of incubation, both G-T30Bodipy and G-
D30Bodipy bound to bacteria. Although the fluorescence intensity appeared to be greater following 
incubation with G-T30Bodipy than G-D30Bodipy for this time point, the BF images reveal that the number 
of bacteria was significantly lower following treatment with G-D30Bodipy. Furthermore, after 30 minutes 
in presence of G-D30Bodipy, most of the visible bacteria possess polymer bound to their surface and a 
compromised membrane, as can be seen with the overlay image of the Bodipy and PI channels, and are 
unhealthy, as indicated by their shape (BF). These pores would allow the polymers to diffuse out of the 
cell, which could explain a reduction in fluorescence intensity. Interestingly, bacteria interacting with 
G-T30Bodipy were also exclusively the ones stained by PI. These results are in contradiction to a study 
from Tew et al., which investigated the effect of guanidinium-functional polyoxanorbornene on the 
membrane integrity of S. aureus using PI.42 Although the polymer showed a bactericidal effect against 
S. aureus, none of the bacteria were stained with PI after 30 minutes, indicating that bacterial membrane 
was not compromised. Comparable observations were reported by Good and co-workers after treatment 
of E.coli with PHMB. No permeability of bacterial membrane was observed in presence of PHMB after 
60 minutes at 37 °C, when using SYTOXⓇ Green as a membrane integrity probe, despite the potency 
of the polymer against E. coli. Following this experiment, it was suggested that complexation of PHMB 
with bacterial DNA was responsible for the antimicrobial character of the polymer, which could also 
be the mechanism of action of guanidinium-functional polyoxanorbornene.67 The disruption of 
membrane integrity associated with G-T30Bodipy and G-D30Bodipy could be due to the action of the 
isopropyl groups of the NIPAM units - the polyoxanorbornene and PHMB did not bear any pendant 
alkyl chains, hence could likely cross bacterial membrane without compromising it.42 In the present 
case, both pore formation and bacterial DNA binding could be occurring and collectively contributing 
towards bacterial death. 
Following incubation with G-D30Bodipy for 2 hours, no bacteria were observed, most probably 
because they were killed and subsequently removed during the washing step. In the presence of G-
T30Bodipy more bacteria were stained after 2 hours of incubation, compared to 30 minutes (Figure 4C). 
Again, co-localisation between G-T30Bodipy and PI reinforces the previous observation that membrane 
disruption is a consequence of polymer binding. The BF image confirms the loss in membrane integrity 
for the majority of bacteria following 2 hours of incubation with G-T30Bodipy. Although no bacteria were 
stained by G-S30Bodipy, even after 2 hours, a few of them were stained with PI. A negative control 
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experiment with PBS and PI was performed and no membrane disruption was found (Figure SI-16). 
Therefore, in the case of G-S30Bodipy, the statistical copolymer would have interacted with JE2 over the 
course of 2 hours, hence inducing membrane disruption, but to a limited extent. 
In summary, G-D30Bodipy underwent stronger interactions with the bacteria compared to G-
T30Bodipy (within 15 to 30 minutes, respectively), whilst G-S30Bodipy only had limited interactions with 
JE2 even after 2 hours (Figure 4C). This trend correlates with the MIC values, as the tested 
concentration (128 μg.mL-1) corresponds to the MIC of G-D30Bodipy and half that of G-T30Bodipy (G-
S30Bodipy was not active up to 1000 μg.mL-1).  
 
3.6. Synthesis and properties of guanidinium homopolymers 
The difference in the MIC values of the guanidinium polymers could be explained by the fact 
that a minimum length of the cationic block is required for the polymer to interact with bacterial 
membrane. To test this hypothesis, guanidinium homopolymers of DP 15 and 30, which corresponds to 
the DP of the cationic block of G-T30 and G-D30, respectively, were synthesized. Similarly to the 
NIPAM copolymers, polyGEAM15 and polyGEAM30 were obtained by RAFT polymerization of 
diBocGEAM followed by hydrolysis to remove the Boc protecting groups (Tables SI-10 and SI-11, 
Figures SI-17, SI-18 and SI-19). 
The antimicrobial activity of the homopolymers was tested against RN1 and JE2 (Figure 5A, Table SI-
12). In the case of the homopolymers, the MIC of polyGEAM15 and polyGEAM30 were similar, meaning 
that the DP did not seem to affect the antimicrobial activity, and a cationic block of DP 15 was sufficient 
to allow interactions with bacterial membrane. However, as G-T30 did not bind as efficiently to bacteria 
as G-D30 (Figure 4), it is plausible that the polyNIPAM block sterically hinders the interaction of the 
polyGEAM block with bacterial membrane in the tetrablock structure. 
The effect of the isopropyl moieties on the antimicrobial activity of the copolymers was evaluated by 
comparing the potency of the copolymers with the cationic homopolymers of similar polyGEAM length. 
If the hydrophobic chains are considered as “non-active” towards bacteria, the standard MIC values 
should be corrected to account for the content of charged “active” moieties of the respective polymers 
by multiplying the MIC expressed in molar concentration with the molar percentage of guanidinium 
functionalities in each polymer. According to Figure 5A, the re-evaluated MIC of G-T30 and G-D30 
was less than half that of polyGEAM15 and polyGEAM30, respectively. This suggests that the 
polyNIPAM blocks participate in the antimicrobial activity of the polymers.  
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Figure 5. Antimicrobial activity and cytotoxicity of the guanidinium homopolymers. (A) Corrected 
MIC of polyGEAM and the guanidinium block copolymers against MRSA strain JE2 obtained by 
multiplying the MIC expressed in molar concentration with the molar percentage of guanidinium 
functionalities in each polymer. (B) Viability of HaCaT cells incubated for 24 hours in presence of 
guanidinium homopolymers and their associated copolymers using an XTT assay. 
 
Additionally, the incorporation of NIPAM rendered the polymers less toxic in vitro towards mammalian 
cells as the cationic homopolymers were toxic at lower concentrations. Indeed, not only did they induce 
hemagglutination (from as low as 2 μg.mL-1), but they were also hemolytic (Figure SI-20 and Table SI-
13). To further investigate the toxicity against mammalian cells, HaCaT cells have been utilized and 
the IC50 was as low as 30 and 60 μg.mL-1 for polyGEAM30 and polyGEAM15, respectively (Figure 5B). 
 
3.7. Effect of segmentation on cell uptake of guanidinium copolymers 
The potency of the SAMPs on intracellular bacteria strongly depends on their ability to enter 
mammalian cells. The uptake of the guanidinium-rich polymers by keratinocytes was studied to 
elucidate the effect of monomer distribution on their internalisation. For this assay, HaCaT cells were 
incubated with the fluorescent polymers at 128 μg.mL-1 for 2 and 16 hours at 37 °C, and the levels of 
uptake were quantified for each compound (Figure 6, Table SI-14). Similar cellular fluorescence was 
observed with G-S30, G-T30 and G-D30 for both 2 and 16 hours. For this system, segmentation does 
not seem to have a significant impact on the internalisation in HaCaT cells. In a previous work using 
guanidinium polymers, we found a decrease in cell uptake with an increase in segmentation of 
functionalities (from statistical to tetrablock to diblock).32 This discrepancy could be explained by the 
hydrophobicity of the co-monomer as the prior study used N,N’-dimethylacrylamide (DMA) and 
hydroxyethylacrylamide (HEA) copolymers. Indeed, there is strong evidence the hydrophobicity of 
cationic polymers influences the cell uptake mechanism.70 
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The uptake of the guanidinium polymers was further investigated by incubating the cells at 4 °C 
for 2 hours. At this temperature, not only would the internalisation via endocytosis be prevented, but 
the overall hydrophilicity of the SAMPs would decrease as the LCST of polyNIPAM is around 37 °C.53 
The internalisation of all three polymers was drastically reduced at 4 °C by over 70 % compared to that 
at 37 °C, indicating that the guanidinium polymers were taken up via both membrane permeation and 
endocytosis within HaCaT cells.32 Although a decrease in internalisation was also observed with the 
DMA and HEA copolymers, the difference in cellular uptake at 37 and 4 °C was not as substantial, 
suggesting that a decrease in hydrophobicity of poly(GEAM-co-NIPAM) would also partly explain the 
reduction in cellular uptake at 4 °C. Moreover, the levels of uptake at 4 °C were comparable for G-S30, 
G-T30 and G-D30. As a result, all three SAMPs would be present in both endosomes and the cytosol, 
as demonstrated with the DMA and HEA copolymers using confocal microscopy.32 Nonetheless, the 
guanidinium containing polymers are very likely to escape from endosomes due to their highly charged 
nature, as established with arginine-rich peptides, hence interact with bacteria present in the cytosol.71-
72 
 
 
Figure 6. Comparison of cell uptake of guanidinium polymers with architecture. Cellular 
fluorescence measured for HaCaT cells in presence of 128 µg.mL-1 of fluorescent guanidinium 
polymers for the indicated time and temperature. *: p ≤ 0.05; **: p ≤ 0.01; ***: p ≤ 0.001. 
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3.8. Effect of segmentation on potency against intracellular bacteria 
Since the antimicrobial effect of the guanidinium polymers was studied in addition to their 
internalisation into mammalian cells, their activity against intracellular bacteria was then explored. In 
order to do so, HaCaT cells were infected with RN1 or JE2 for 2 hours and were then treated with a 
mixture of gentamicin and lysostaphin to kill extracellular bacteria as described in the literature.73 
Finally, the cells were incubated with the guanidinium compounds at a non-cytotoxic concentration of 
128 μg.mL-1 for 2 hours. Lysostaphin was used as a negative control as this enzyme is known to be 
ineffective against intracellular bacteria while killing any extracellular bacteria, which can be released 
by infected cells.3 At the end of the polymer treatment, the cells were lysed, diluted, and plated to obtain 
bacterial counts (Figure 7). 
 
Similar levels of intracellular MSSA RN1 were recovered with G-S30 and G-T30 compared to 
lysostaphin, meaning that the polymers would have inhibited the proliferation of extracellular bacteria 
released during the treatment. This would help containing the infection to an extent but would not be 
sufficient to treat infections. Interestingly, G-D30 was the most active for intracellular RN1, reducing 
the number of bacteria by two-fold compared to lysostaphin (Figure 7A). Similarly, G-D30 was active 
against intracellular JE2 with only half of the intracellular bacteria surviving compared to the 
lysostaphin, G-S30 and G-T30 treatments (Figure 7B). Although all three compounds were shown to 
be taken up in keratinocytes at similar levels (Figure 6), G-D30 exhibited the highest antimicrobial 
activity towards both RN1 and JE2 (Figure 3A and B), hence a corresponding increased intracellular 
killing efficiency compared to its statistical and tetrablock counterparts. 
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Figure 7. Intracellular activity of guanidinium polymers in HaCaT cells. Bacterial colony counts 
of intracellular bacteria after a polymer treatment at 128 μg.mL-1 for 2 hours against RN1 (A) and JE2 
(B). Treatment with G-D30 at 40 μg.mL-1 for 2 hours against RN1 (C) and JE2 (D). *: p ≤ 0.05; **: p 
≤ 0.01; ***: p ≤ 0.001. 
 
 
Since G-D30 was active against intracellular bacteria at 128 μg.mL-1, it was also tested at 40 μg.mL-
1 for 2 hours. G-D30 induced a similar inhibition level of 50 % against RN1 at the lower concentration 
(Figure 7C). However, the guanidinium diblock was not effective against intracellular JE2 at 40 μg.mL-
1 (Figure 7D). A possible explanation could be that, as previously discussed, JE2 is less susceptible to 
SAMPs compared to RN1 due to its resistance to methicillin. As G-D30 did not exhibit any toxicity at 
128 μg.mL-1 against the various types of human cells tested, it may be a promising therapeutic candidate 
for extracellular and intracellular killing of MRSA and MSSA. 
 
 
 
4. Conclusion 
Ammonium and guanidinium copolymers containing NIPAM as co-monomer were successfully 
synthesized via RAFT polymerization. By varying both the nature of the cationic functionality and the 
monomer distribution (statistical, tetrablock and diblock copolymers), the effect of charge and 
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segregation of functionalities on the biological properties of SAMPs was elucidated with both sets of 
polymers. Although the diblock copolymers exhibited a slightly higher toxicity towards epithelial cells 
than their statistical and tetrablock counterparts, they were associated with an improved 
hemocompatibility by a reduced hemagglutination activity. More importantly, segregation of the 
cationic and hydrophobic functionalities drastically improved the potency against S. aureus. 
The diblock guanidinium polymer G-D30 particularly attracted our interest as it inhibited the 
growth of both intracellular MSSA and MRSA by 50 % over 2 hours. Its statistical and tetrablock 
analogues did not show any activity towards intracellular S. aureus although they were shown to be 
internalized at similar level as G-D30 via both active and passive mechanisms. Indeed, G-D30 was 
demonstrated to be the most efficient at attaching to bacterial membrane, followed by G-T30, whilst no 
binding was observed with G-S30. This reduced interaction could be attributed to the isopropyl 
functionalities hindering the guanidinium moieties from interacting with the negatively charged 
phospholipids present on bacterial membranes. Nonetheless, there is strong evidence that these 
hydrophobic functionalities are key for both the antimicrobial activity and the internalisation into 
mammalian cells. The isopropyl functionalities from the polyNIPAM block of G-D30 and G-T30 were 
probably responsible for permeabilising bacterial membrane as previous work with guanidinium 
containing homopolymers did not demonstrate this property. Therefore, the optimized sequence for the 
killing of intracellular and extracellular MRSA appears to be the guanidinium diblock copolymer 
structure, which could find applications in the treatment of infections, whilst limiting antibiotic induced-
bacterial resistance.2 In order to further reduce the amount of intracellular bacteria, variation in the 
hydrophobic functionality or overall charge content could be investigated.  
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